知情人士透露，淡马锡控股（Temasek Holdings）和新加坡政府投资公司（GIC）将收购Novotech私人有限公司的大量股份，以促进这家临床研究和测试服务供应商的增长并加速收购。这项交易对公司的估值约为30亿澳元（25亿新元）。 Novotech的支持者TPG则将通过它的53亿 ...

SYDNEY, April 02, 2025--(BUSINESS WIRE)--Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized ...

SYDNEY, April 02, 2025--(BUSINESS WIRE)--Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized ...

Novotech, a global leading full-service clinical Contract Research Organization (CRO), and Acrostar, a provider of Site Management Organization (SMO) services have entered into a strategic ...

[SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a “significant stake in the company”, and that existing investor TPG will be ...

Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30. GIC and Temasek have invested in Novotech with the goal of providing funds ...

Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a ...

Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance ...

SYDNEY, March 06, 2025--(BUSINESS WIRE)--Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of ...